Tuberculosis screening and management of latent tuberculosis infection prior to biologic treatment in patients with immune-mediated inflammatory diseases: A longitudinal population-based analysis using claims data.
Arisa IbaJun TomioHayato YamanaTakahiro SugiyamaTakashi YoshiyamaYasuki KobayashiPublished in: Health science reports (2020)
There was low adherence to the recommendations for tuberculosis screening and prophylactic treatment before biologic therapy. It is necessary to continue alerting clinical practitioners to the importance of screening for tuberculosis and treatment for LTBI.
Keyphrases
- mycobacterium tuberculosis
- rheumatoid arthritis
- oxidative stress
- type diabetes
- stem cells
- emergency department
- combination therapy
- machine learning
- electronic health record
- health insurance
- hepatitis c virus
- bone marrow
- skeletal muscle
- hiv infected
- adverse drug
- antiretroviral therapy
- artificial intelligence
- chemotherapy induced